Comment on: Oncological outcomes after transanal total mesorectal excision for rectal cancer
Br J Surg
.
2023 Oct 10;110(11):1557.
doi: 10.1093/bjs/znad260.
Authors
Mahir Gachabayov
1
,
Roberto Bergamaschi
1
,
Hans Wasmuth
2
,
Arne Faerden
3
,
Mirkhalig Javadov
4
,
Fabio Cianchi
5
,
Yosef Nasseri
6
,
Moshe Barnajian
6
,
Dorin E Popa
7
,
Hanjoo Lee
8
Affiliations
1
Section of Colorectal Surgery, New York Medical College, Westchester Medical Center, Valhalla, New York, USA.
2
Department of Gastrointestinal Surgery, St Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.
3
Department of Digestive Surgery, Akershus University Hospital, Akershus, Norway.
4
Department of Surgery, Yeditepe University Hospital, Istanbul, Turkey.
5
Department of Surgery and Translational Medicine, Careggi Hospital, University of Florence, Florence, Italy.
6
Division of Colorectal Surgery, Cedar Sinai Medical Center, Los Angeles, California, USA.
7
Department of Surgery, Linköping University Hospital, Linköping, Sweden.
8
Division of Colon and Rectal Surgery, Harbor-UCLA Medical Center, Torrance, California, USA.
PMID:
37566473
DOI:
10.1093/bjs/znad260
No abstract available